GS
Goldman Sachs Group Inc cut its KPTI stake below 5%
Goldman Sachs Group Inc reported owning 0.9% of Karyopharm Therapeutics Inc. (KPTI) (203,129 shares) in a Schedule 13G filed Nov 9, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 9, 2026
- Source
- Schedule 13G